Literature DB >> 29264727

Concentration of Proteasome in the Blood Plasma of Children with Acute Appendicitis, Before and After Surgery, and Its Correlation with CRP.

Ewa Matuszczak1, Marzena Tylicka2, Wojciech Dębek3, Anna Sankiewicz4, Ewa Gorodkiewicz4, Adam Hermanowicz3.   

Abstract

OBJECTIVE: The determination of 20S proteasome concentration in the blood plasma of children with appendicitis and its correlation with CRP. DESIGN AND
SETTING: Thirty-one children with acute appendicitis, were randomly included into the study (age 5 years up to 17 years, mean age 11.5 + 1 years). PARTICIPANTS: There were 17 girls and 14 boys. Eighteen healthy, age-matched subjects, admitted for planned surgeries served as controls. Exclusion criteria were: severe preexisting infections, immunological or cardiovascular diseases that required long-term medication, and complicated cases of appendicitis with perforation of appendix and/or peritonitis. MAIN OUTCOME MEASURES: The 20S proteasome concentrations in the blood plasma of patients with acute appendicitis were highest before the surgery and were above the range of concentrations measured in controls, and the difference was statistically significant.
RESULTS: The 20S proteasome concentration measured 24 and 72 h after the operation, slowly decreased over time, and still did not reach the normal range, when compared with the concentration measured in controls (p < 0.05).
CONCLUSIONS: 20S proteasome concentration may reflect the metabolic response to acute state inflammation, and the process of gradual ebbing of the inflammation. The method of operation-classic open appendectomy, or laparoscopic appendectomy, does not influence the general trend in 20S proteasome concentration.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29264727     DOI: 10.1007/s00268-017-4407-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

1.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors.

Authors:  B Johnsson; S Löfås; G Lindquist
Journal:  Anal Biochem       Date:  1991-11-01       Impact factor: 3.365

2.  The comparison of C-proteasome activity in the plasma of children after burn injury, mild head injury and blunt abdominal trauma.

Authors:  Ewa Matuszczak; Marzena Tylicka; Wojciech Dębek; Adam Hermanowicz; Halina Ostrowska
Journal:  Adv Med Sci       Date:  2015-05-11       Impact factor: 3.287

Review 3.  Ubiquitin-dependent protein degradation.

Authors:  M Hochstrasser
Journal:  Annu Rev Genet       Date:  1996       Impact factor: 16.830

4.  The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.

Authors:  S Hussain; O Foreman; S L Perkins; T E Witzig; R R Miles; J van Deursen; P J Galardy
Journal:  Leukemia       Date:  2010-06-24       Impact factor: 11.528

5.  UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.

Authors:  Yiting Jin; Wei Zhang; Jiawen Xu; Hongying Wang; Zijing Zhang; Chengyu Chu; Xiuping Liu; Qiang Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.

Authors:  Jun Yu; Qian Tao; Kin F Cheung; Hongchuan Jin; Fan Fong Poon; Xian Wang; Hongyu Li; Yuen Y Cheng; Christoph Röcken; Matthias P A Ebert; Anthony T C Chan; Joseph J Y Sung
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

7.  SPR imaging biosensor for the 20S proteasome: sensor development and application to measurement of proteasomes in human blood plasma.

Authors:  Ewa Gorodkiewicz; Halina Ostrowska; Anna Sankiewicz
Journal:  Mikrochim Acta       Date:  2011-07-24       Impact factor: 5.833

8.  Activation of Cell Surface Bound 20S Proteasome Inhibits Vascular Cell Growth and Arteriogenesis.

Authors:  Wulf D Ito; Natalie Lund; Ziyang Zhang; Friedrich Buck; Heinrich Lellek; Andrea Horst; Hans-Günther Machens; Heribert Schunkert; Wolfgang Schaper; Thomas Meinertz
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

9.  UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression.

Authors:  Sajjad Hussain; Tibor Bedekovics; Marta Chesi; P Leif Bergsagel; Paul J Galardy
Journal:  Oncotarget       Date:  2015-12-01

10.  Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.

Authors:  Caroline L Wilson; Lindsay B Murphy; Jack Leslie; Stuart Kendrick; Jeremy French; Christopher R Fox; Neil S Sheerin; Andrew Fisher; John H Robinson; Dina G Tiniakos; Douglas A Gray; Fiona Oakley; Derek A Mann
Journal:  J Hepatol       Date:  2015-08-08       Impact factor: 25.083

View more
  1 in total

Review 1.  Concept and application of circulating proteasomes.

Authors:  Won Hoon Choi; Sumin Kim; Seoyoung Park; Min Jae Lee
Journal:  Exp Mol Med       Date:  2021-10-27       Impact factor: 8.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.